BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29420574)

  • 21. The Population Ecology of Technology: An Empirical Study of US Biotechnology Patents from 1976 to 2003.
    van den Oord A; van Witteloostuijn A
    PLoS One; 2017; 12(1):e0169961. PubMed ID: 28081570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patenting and licensing of university-based genetic inventions--a view from experience at Stanford University's Office of Technology Licensing.
    Leute K
    Community Genet; 2005; 8(4):217-22. PubMed ID: 16244475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technology transfer at US universities: seeking public benefit from the results of basic research.
    Goodwin CD
    Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.
    Cockburn I; Long G
    Expert Opin Ther Pat; 2015 Jul; 25(7):739-42. PubMed ID: 25927945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biotechnology research and generation of patents of interest to the health system].
    Plaza Gómez L; Albert Martínez A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():55-9. PubMed ID: 19631824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hundred years' psychiatry in Korea (1899-1999)].
    Rhi BY
    Uisahak; 1999; 8(2):157-68. PubMed ID: 12212610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patent data mining: a tool for accelerating HIV vaccine innovation.
    Clark K; Cavicchi J; Jensen K; Fitzgerald R; Bennett A; Kowalski SP
    Vaccine; 2011 May; 29(24):4086-93. PubMed ID: 21496469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The academic advantage: gender disparities in patenting.
    Sugimoto CR; Ni C; West JD; Larivière V
    PLoS One; 2015; 10(5):e0128000. PubMed ID: 26017626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WARF's stem cell patents and tensions between public and private sector approaches to research.
    Golden JM
    J Law Med Ethics; 2010; 38(2):314-31. PubMed ID: 20579254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new patent-based approach for technology mapping in the pharmaceutical domain.
    Russo D; Montecchi T; Carrara P
    Pharm Pat Anal; 2013 Sep; 2(5):611-27. PubMed ID: 24237169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEs.
    Kang KN; Lee YS
    Biotechnol Lett; 2008 Oct; 30(10):1699-704. PubMed ID: 18506395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technology networks: the autocatalytic origins of innovation.
    Napolitano L; Evangelou E; Pugliese E; Zeppini P; Room G
    R Soc Open Sci; 2018 Jun; 5(6):172445. PubMed ID: 30110482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualization of e-Health Research Topics and Current Trends Using Social Network Analysis.
    Son YJ; Jeong S; Kang BG; Kim SH; Lee SK
    Telemed J E Health; 2015 May; 21(5):436-42. PubMed ID: 25885639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between academic institutions and industry in the life sciences--an industry survey.
    Blumenthal D; Causino N; Campbell E; Louis KS
    N Engl J Med; 1996 Feb; 334(6):368-73. PubMed ID: 8538709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Licensing biotech intellectual property in university-industry partnerships.
    Drozdoff V; Fairbairn D
    Cold Spring Harb Perspect Med; 2015 Jan; 5(3):a021014. PubMed ID: 25605752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commercialization, patents and moral assessment of biotechnology products.
    Hoedemaekers R
    J Med Philos; 2001 Jun; 26(3):273-84. PubMed ID: 11445882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act.
    Berman EP
    Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.